Search - tctmd.com

Displaying 21 - 40 of 163

Sort: Relevancy | Date

News Daily News

Routine IVUS in Peripheral Interventions Supported by Small RCT

L.A. McKeown

March 09, 2022

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Conference News ACC 2021

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

L.A. McKeown

May 16, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

L.A. McKeown

January 12, 2021

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

News Daily News

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Caitlin E. Cox

March 18, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Conference News ISET 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Caitlin E. Cox

February 05, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

News Conference News VEITH 2019

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

L.A. McKeown

November 28, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

Advertisement

Routine IVUS in Peripheral Interventions Supported by Small RCT

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

March 2021 News Roundup

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content